IP Library Granted Patent US 9,409,019
Granted Patent B2
US 9,409,019 · App. 14/617,745 · Granted Aug 9, 2016

Linked area parameter adjustment for spinal cord stimulation and associated systems and methods

Inventors: Andre B. Walker (Monte Sereno, CA); Jon Parker (San Jose, CA)
Assignee: Nevro Corporation
A61N1/36071A61N1/0551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,409,019
App. No.
14/617,745
Granted
Aug 9, 2016
Kind
B2
Abstract

Systems and methods for managing pain in a patient using an electrical waveform that link the modulation of a waveform parameter for different areas of a patient. One embodiment in a system for managing pain in a patient comprises an electric device configured to be implanted into the patient and including a plurality of electrodes having at least a first electrode associated with a first area of the patient and a second electrode associated with a second area of the patient. The system further includes an implantable device configured to be coupled to the electrode device and having a computer-operable medium programmed to change the waveform parameter applied to the first electrode and automatically set the waveform parameter applied to the second electrode based on a relationship between a first therapy range and a second therapy range of the waveform parameter.

Claims (76)

1. A system for managing pain in a patient, using an electrical waveform, comprising:

an electrode device configured to be implanted into a patient and including a plurality of electrodes having at least a first electrode associated with a first area of the patient and a second electrode associated with a second area of the patient, wherein the first area has a first therapy range for a waveform parameter and the second area has a second therapy range for the waveform parameter; and

an implantable device configured to be coupled to the electrode device, the implantable device including a waveform generator configured to generate a non-paresthesia-producing therapy signal, and a computer-operable medium operatively coupled to the waveform generator, the computer-operable medium being programmed to—

direct the non-paresthesia-producing therapy signal to the electrode device with a frequency from 1.5 kHz to 100 kHz;

change a level of a waveform parameter applied to the first electrode; and

automatically set a level of the waveform parameter applied to the second electrode, based on a scaling factor relating the first therapy range to the second therapy range.

2. The system of claim 1 wherein the scaling factor is a ratio of the second therapy range to the first therapy range.

3. The system of claim 1 wherein the therapy ranges are ranges of the waveform parameter that provide a therapeutic effect without inducing discomfort.

4. The system of claim 1 wherein the computer-operable medium is programmed to:

change the waveform parameter applied to the first electrode by a first increment; and

change the waveform parameter applied to the second electrode by a second increment, the second increment being proportional to a ratio of the second therapy range to the first therapy range.

5. The system of claim 1 wherein the computer-operable medium is programmed to receive a plurality of change command inputs, and wherein:

the scaling factor is a ratio of the second therapy range to the first therapy range;

the waveform parameter applied to the first electrode is changed by a first increment for each change command input; and

for each change command input, the waveform parameter applied to the second electrode is set by (a) changing the waveform parameter applied to the second electrode by the first increment or (b) holding the waveform parameter applied to the second electrode constant.

6. The system of claim 1 wherein the computer-operable medium is programmed to prevent the waveform parameter applied to the first electrode from exceeding a first maximum and prevent the waveform parameter applied to the second electrode from exceeding a second maximum.

7. The system of claim 1 wherein the waveform parameter comprises a waveform amplitude.

8. The system of claim 1 wherein the waveform parameter comprises an impedance between a remote electrode and each of the first electrode at the first area and the second electrode at the second area.

9. The system of claim 1 wherein the waveform parameter comprises waveform power.

10. The system of claim 1 wherein:

the first therapy range corresponds to a difference between (a) a first sensation threshold and/or a first therapeutic threshold and (b) a first discomfort threshold for the first area; and

the second therapy range corresponds to a difference between (a) a second sensation threshold and/or a second therapeutic threshold and (b) a second discomfort threshold for the second area.

11. The system of claim 1 wherein the computer-operable medium is programmed to:

store diagnostics including a plurality of observed patient usage patterns; and

transmit the diagnostics of observed patient usage patterns to a remote processor that determines the first therapy range, the second therapy range, and a ratio of the second therapy range to the first therapy range.

12. The system of claim 1 wherein the computer-operable medium is programmed to:

determine a first ratio of the second therapy range to the first therapy range associated with a first patient position;

determine a second ratio of the second therapy range to the first therapy range associated with a second patient position; and

change the waveform parameter applied to the first and second electrodes based on the first ratio when the patient is in the first position or based on the second ratio when the patient is in the second position.

13. The system of claim 1 wherein the computer-operable medium is programmed to:

receive a first maximum for the waveform parameter applied to the first electrode and set a second maximum for the waveform parameter applied to the second electrode; and

decouple the second electrode from the first electrode for adjustment of the parameter when one of the first or second electrodes has reached the first or second maximum, respectively.

14. The system of claim 1 wherein the computer-operable medium is programmed to:

change the waveform parameter applied to the first electrode by a first increment; and

change the waveform parameter applied to the second electrode by a second increment, wherein the second increment is the product of the first increment and a ratio of the second therapy range to the first therapy range.

15. A spinal cord modulation system, comprising:

a signal delivery device having a proximal portion and a distal portion, wherein the distal portion includes a plurality of electrodes having at least a first electrode associated with a first area of the patient and a second electrode associated with a second area of the patient, wherein the first area has a first therapy range for a waveform parameter and the second area has a second therapy range for the waveform parameter; and

a pulse generator coupleable to the proximal portion of the signal delivery device and programmed with instructions that, when executed:

generate and transmit to the signal delivery device a non-paresthesia-producing therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz;

change a level of a waveform parameter applied to the first electrode; and

automatically set a level of the waveform parameter applied to the second electrode, based on a relationship between the first therapy range and the second therapy range.

16. The system of claim 15 wherein the relationship includes a scaling factor relating the first therapy range to the second therapy range.

17. The system of claim 16 wherein the scaling factor is a ratio of the second therapy range to the first therapy range.

18. The system of claim 15 wherein the therapy signal has an amplitude between 0.1 mA and 20 mA.

19. The system of claim 15 wherein the therapy signal has a plurality of biphasic pulses having a pulse width between 10 microseconds and 333 microseconds.

20. The system of claim 15 , wherein the pulse generator is an implantable pulse generator.

21. The system of claim 15 , wherein the pulse generator is an external pulse generator.

22. The system of claim 15 , wherein the signal delivery device includes an elongated lead.

23. The system of claim 15 , wherein the signal delivery device includes a paddle lead.

24. The system of claim 15 wherein the pulse generator is programmed to:

change the waveform parameter applied to the first electrode by a first increment; and

change the waveform parameter applied to the second electrode by a second increment, the second increment being proportional to a ratio of the second therapy range to the first therapy range.

25. The system of claim 15 wherein the pulse generator is programmed to receive a plurality of change command inputs, and wherein:

the scaling factor is a ratio of the second therapy range to the first therapy range;

the waveform parameter applied to the first electrode is changed by a first increment for each change command input; and

for each change command input, the waveform parameter applied to the second electrode is set by (a) changing the waveform parameter applied to the second electrode by the first increment or (b) holding the waveform parameter applied to the second electrode constant.

26. The system of claim 15 wherein the pulse generator is programmed to prevent the waveform parameter applied to the first electrode from exceeding a first maximum and prevent the waveform parameter applied to the second electrode from exceeding a second maximum.

27. The system of claim 15 wherein the waveform parameter comprises a waveform amplitude.

28. The system of claim 15 wherein the waveform parameter comprises an impedance between a remote electrode and each of the first electrode at the first area and the second electrode at the second area.

29. The system of claim 15 wherein the waveform parameter comprises waveform power.

30. The system of claim 15 wherein:

the first therapy range corresponds to a difference between (a) a first sensation threshold and/or a first therapeutic threshold and (b) a first discomfort threshold for the first area; and

the second therapy range corresponds to a difference between (a) a second sensation threshold and/or a second therapeutic threshold and (b) a second discomfort threshold for the second area.

31. The system of claim 15 wherein the pulse generator is programmed to:

store diagnostics including a plurality of observed patient usage patterns; and

transmit the diagnostics of observed patient usage patterns to a remote processor that determines the first therapy range, the second therapy range, and a ratio of the second therapy range to the first therapy range.

32. The system of claim 15 wherein the pulse generator is programmed to:

determine a first ratio of the second therapy range to the first therapy range associated with a first patient position;

determine a second ratio of the second therapy range to the first therapy range associated with a second patient position; and

change the waveform parameter applied to the first and second electrodes based on the first ratio when the patient is in the first position or based on the second ratio when the patient is in the second position.

33. The system of claim 15 wherein the pulse generator is programmed to:

receive a first maximum for the waveform parameter applied to the first electrode and set a second maximum for the waveform parameter applied to the second electrode; and

decouple the second electrode from the first electrode for adjustment of the parameter when one of the first or second electrodes has reached the first or second maximum, respectively.

34. The system of claim 15 wherein the pulse generator is programmed to:

change the waveform parameter applied to the first electrode by a first increment; and

change the waveform parameter applied to the second electrode by a second increment, wherein the second increment is the product of the first increment and a ratio of the second therapy range to the first therapy range.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 034938 FRAME: 0163. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 17, 2016
From: WALKER, ANDRE B.; PARKER, JON
To: NEVRO CORP.
Reel/Frame 040645/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2015
From: WALKER, ANDRE B.; PARKER, JON
To: NEVRO CORPORATION
Reel/Frame 034938/0163 →
Continuity (4)
Continuation 14226644 · Mar 26, 2014
Continuation 13914494 · Jun 10, 2013
Continuation 12510930 · Jul 28, 2009
Related Publication 20150217113A1 · Aug 6, 2015